Featured Publications
Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-targeted Pneumococcal Serotypes Among Adults
Warren JL, Pingali SC, Weinberger DM. Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-targeted Pneumococcal Serotypes Among Adults. Epidemiology 2017, 28: 119-126. PMID: 27541841, PMCID: PMC5131859, DOI: 10.1097/ede.0000000000000551.Peer-Reviewed Original ResearchConceptsVaccine-targeted serotypesInvasive pneumococcal disease casesPneumococcal disease casesDirect vaccinationDisease casesInvasive pneumococcal diseaseConjugate vaccinePneumococcal diseaseVaccine serotypesVaccine uptakePneumococcal serotypesLeading causeBaseline proportionRate of declineNumber of casesAdult populationVaccinationStudy periodVaccineSerotypesAdultsChildrenHigh levelsMorbidityGeographic regions
2022
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Prunas O, Warren JL, Crawford FW, Gazit S, Patalon T, Weinberger DM, Pitzer VE. Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science 2022, 375: eabl4292. PMID: 35084937, PMCID: PMC9261115, DOI: 10.1126/science.abl4292.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Syndrome coronavirus 2Effectiveness of vaccinesEffectiveness of vaccinationTotal vaccine effectivenessSARS-CoV-2Household contactsSecond doseCoronavirus 2Household transmissionDelta variantDay 10VaccinationBNT162b2COVID-19InfectionChain binomial modelVaccineDoseImmunity